Compounds > sk&f 104856
Page last updated: 2024-09-03

sk&f 104856 and 3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione

sk&f 104856 has been researched along with 3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione in 1 studies

Compound Research Comparison

Studies
(sk&f 104856)		Trials
(sk&f 104856)		Recent Studies (post-2010)
(sk&f 104856)		Studies
(3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione)		Trials
(3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione)		Recent Studies (post-2010) (3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione)
1400904

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botta, M; Cagnotto, A; Manetti, F; Materia, L; Mennini, T; Minneman, KP; Nicoletti, F; Romeo, G; Russo, F1

Other Studies

1 other study(ies) available for sk&f 104856 and 3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione

ArticleYear
New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14

    Topics: Adrenergic alpha-Antagonists; Animals; Cell Line; Computer Simulation; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship

2003